Year: 2026
Type: article
Abstract: InflammAging (IA) is a sterile, low-grade systemic inflammation characterizing human aging. This chronic inflammatory state, combining "inflammation" and "aging", drives the aging trajectory and associated pathology even in the absence of acute clinical signs. IA is a key etiological factor for numerous age-associated diseases, including neurodegeneration (e.g., Alzheimer's disease), cardiovascular disorders, diabetes, sarcopenia, cancer, frailty, and multimorbidity, by exacerbating tissue/organ damage and impairing endogenous repair. Historically viewed as a universal hallmark of aging, this concept is now being refined. Current research highlights how human diversity-encompassing genetic, ethnic, gender, sex, environmental, socioeconomic, and lifestyle variations-could modulate the expression and severity of IA. This interplay, as emerging hypotheses, represents a new horizon in gerontology and chronic diseases, necessitating a potential paradigm shift from a one-size-fits-all model to personalized, population-specific approaches. This evolving nuanced understanding might be crucial for the successful implementation of precision medicine and for advancing global health strategies targeting age-related chronic diseases.
Source: Aging and Disease
Author: José M. Izquierdo
Language: English
Subfield: Aging
Domain: Life Sciences
Keywords: inflammaging, low-grade inflammation, aging, age-related chronic diseases, human diversity, genetic variation, ethnic differences, sex differences, socioeconomic factors, lifestyle factors, Alzheimer's disease, frailty, multimorbidity, sarcopenia, diabetes mellitus, cardiovascular disease, cancer, precision medicine, personalized medicine
Open Access status: gold
Estimated APC paid: $2,000
OpenAlex ID: W7154013521
